NRB Bearings Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 12, 2025, 12:02 pm

Quick Insight

NRB Bearings Ltd, with a share price of 284 and a market cap of 2,762 Cr., presents a compelling investment opportunity with a P/E ratio of 20.5 and a solid ROE and ROCE of 12.7% and 15.9% respectively. The company's operational performance is robust, with an OPM of 17% and a healthy net profit of 82 Cr. Furthermore, the shareholder distribution showcases a strong promoter holding of 51.20%, indicating confidence in the business. With a comfortable P/BV of 2.13x and a strong ICR of 20.21x, NRB Bearings Ltd seems well-positioned for growth and value creation.

Competitors of NRB Bearings Ltd

All Competitor Stocks of NRB Bearings Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:05 am

Below is a detailed analysis of the quarterly data for NRB Bearings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 310.00 Cr.. The value appears to be declining and may need further review. It has decreased from 329.00 Cr. (Mar 2025) to 310.00 Cr., marking a decrease of 19.00 Cr..
• For Expenses, as of Jun 2025, the value is 259.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 269.00 Cr. (Mar 2025) to 259.00 Cr., marking a decrease of 10.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Mar 2025) to 51.00 Cr., marking a decrease of 9.00 Cr..
• For OPM %, as of Jun 2025, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Mar 2025) to 17.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from -45.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 54.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 45.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 45.00 Cr., marking an increase of 44.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 284.00% (Mar 2025) to 27.00%, marking a decrease of 257.00%.
• For Net Profit, as of Jun 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Mar 2025) to 33.00 Cr., marking an increase of 34.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.31. The value appears strong and on an upward trend. It has increased from -0.21 (Mar 2025) to 3.31, marking an increase of 3.52.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:21 pm

Growth

Last Updated: September 5, 2025, 11:50 am

Balance Sheet

Last Updated: September 10, 2025, 2:10 pm

Below is a detailed analysis of the balance sheet data for NRB Bearings Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 19.00 Cr..
• For Reserves, as of Mar 2025, the value is 899.00 Cr.. The value appears strong and on an upward trend. It has increased from 841.00 Cr. (Mar 2024) to 899.00 Cr., marking an increase of 58.00 Cr..
• For Borrowings, as of Mar 2025, the value is 187.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 178.00 Cr. (Mar 2024) to 187.00 Cr., marking an increase of 9.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 201.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 201.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,306.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,239.00 Cr. (Mar 2024) to 1,306.00 Cr., marking an increase of 67.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 377.00 Cr.. The value appears strong and on an upward trend. It has increased from 337.00 Cr. (Mar 2024) to 377.00 Cr., marking an increase of 40.00 Cr..
• For CWIP, as of Mar 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2024) to 40.00 Cr., marking a decrease of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 14.00 Cr..
• For Other Assets, as of Mar 2025, the value is 832.00 Cr.. The value appears strong and on an upward trend. It has increased from 815.00 Cr. (Mar 2024) to 832.00 Cr., marking an increase of 17.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,306.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,239.00 Cr. (Mar 2024) to 1,306.00 Cr., marking an increase of 67.00 Cr..

Notably, the Reserves (899.00 Cr.) exceed the Borrowings (187.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for NRB Bearings Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.20. This value is within the healthy range. It has decreased from 24.71 (Mar 24) to 8.20, marking a decrease of 16.51.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.20. This value is within the healthy range. It has decreased from 24.71 (Mar 24) to 8.20, marking a decrease of 16.51.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.41. This value is within the healthy range. It has decreased from 29.39 (Mar 24) to 13.41, marking a decrease of 15.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 94.75. It has increased from 90.40 (Mar 24) to 94.75, marking an increase of 4.35.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 94.75. It has increased from 90.40 (Mar 24) to 94.75, marking an increase of 4.35.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 123.70. It has increased from 112.90 (Mar 24) to 123.70, marking an increase of 10.80.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 23.10. This value is within the healthy range. It has increased from 20.02 (Mar 24) to 23.10, marking an increase of 3.08.
• For PBIT / Share (Rs.), as of Mar 25, the value is 18.19. This value is within the healthy range. It has increased from 15.55 (Mar 24) to 18.19, marking an increase of 2.64.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.70. This value is within the healthy range. It has decreased from 32.60 (Mar 24) to 11.70, marking a decrease of 20.90.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 24.92 (Mar 24) to 8.50, marking a decrease of 16.42.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.20. This value is within the healthy range. It has decreased from 24.71 (Mar 24) to 8.20, marking a decrease of 16.51.
• For PBDIT Margin (%), as of Mar 25, the value is 18.67. This value is within the healthy range. It has increased from 17.73 (Mar 24) to 18.67, marking an increase of 0.94.
• For PBIT Margin (%), as of Mar 25, the value is 14.70. This value is within the healthy range. It has increased from 13.77 (Mar 24) to 14.70, marking an increase of 0.93.
• For PBT Margin (%), as of Mar 25, the value is 9.45. This value is below the healthy minimum of 10. It has decreased from 28.87 (Mar 24) to 9.45, marking a decrease of 19.42.
• For Net Profit Margin (%), as of Mar 25, the value is 6.86. This value is within the healthy range. It has decreased from 22.07 (Mar 24) to 6.86, marking a decrease of 15.21.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.62. This value is below the healthy minimum of 8. It has decreased from 21.88 (Mar 24) to 6.62, marking a decrease of 15.26.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.65. This value is below the healthy minimum of 15. It has decreased from 27.84 (Mar 24) to 8.65, marking a decrease of 19.19.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.42. This value is within the healthy range. It has increased from 16.23 (Mar 24) to 18.42, marking an increase of 2.19.
• For Return On Assets (%), as of Mar 25, the value is 6.11. This value is within the healthy range. It has decreased from 19.32 (Mar 24) to 6.11, marking a decrease of 13.21.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 24) to 0.00, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.20.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.94. It has increased from 0.89 (Mar 24) to 0.94, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 2.40. This value is within the healthy range. It has decreased from 2.54 (Mar 24) to 2.40, marking a decrease of 0.14.
• For Quick Ratio (X), as of Mar 25, the value is 1.12. This value is within the healthy range. It has decreased from 1.19 (Mar 24) to 1.12, marking a decrease of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 4. It has decreased from 1.13 (Mar 24) to 1.08, marking a decrease of 0.05.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 20.64 (Mar 24) to 0.00, marking a decrease of 20.64.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 17.48 (Mar 24) to 0.00, marking a decrease of 17.48.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 79.36 (Mar 24) to 0.00, marking a decrease of 79.36.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 82.52 (Mar 24) to 0.00, marking a decrease of 82.52.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 20.21. This value is within the healthy range. It has increased from 8.71 (Mar 24) to 20.21, marking an increase of 11.50.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.11. This value is within the healthy range. It has increased from 3.43 (Mar 24) to 13.11, marking an increase of 9.68.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,105.12. It has decreased from 2,686.17 (Mar 24) to 2,105.12, marking a decrease of 581.05.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.76. This value is within the healthy range. It has decreased from 2.46 (Mar 24) to 1.76, marking a decrease of 0.70.
• For EV / EBITDA (X), as of Mar 25, the value is 9.40. This value is within the healthy range. It has decreased from 13.84 (Mar 24) to 9.40, marking a decrease of 4.44.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has decreased from 2.37 (Mar 24) to 1.63, marking a decrease of 0.74.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 79.35 (Mar 24) to 0.00, marking a decrease of 79.35.
• For Price / BV (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has decreased from 3.02 (Mar 24) to 2.13, marking a decrease of 0.89.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has decreased from 2.37 (Mar 24) to 1.63, marking a decrease of 0.74.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.04, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness